Bluebird Bio Valuation
| BLUEDelisted Stock | USD 4.97 0.23 4.85% |
At this time, the firm appears to be overvalued. Bluebird Bio shows a prevailing Real Value of $3.87 per share. The current price of the firm is $4.97. Our model approximates the value of Bluebird Bio from analyzing the firm fundamentals such as Profit Margin of (1.92) %, return on equity of -5.47, and Current Valuation of 158.07 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bluebird Bio's price fluctuation is dangerous at this time. Calculation of the real value of Bluebird Bio is based on 3 months time horizon. Increasing Bluebird Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bluebird stock is determined by what a typical buyer is willing to pay for full or partial control of Bluebird Bio. Since Bluebird Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bluebird Stock. However, Bluebird Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.97 | Real 3.87 | Hype 4.7 | Naive 4.68 |
The real value of Bluebird Stock, also known as its intrinsic value, is the underlying worth of Bluebird Bio Company, which is reflected in its stock price. It is based on Bluebird Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bluebird Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bluebird Bio helps investors to forecast how Bluebird stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bluebird Bio more accurately as focusing exclusively on Bluebird Bio's fundamentals will not take into account other important factors: Bluebird Bio Total Value Analysis
Bluebird Bio is currently anticipated to have valuation of 158.07 M with market capitalization of 48.67 M, debt of 358.24 M, and cash on hands of 132.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bluebird Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
158.07 M | 48.67 M | 358.24 M | 132.51 M |
Bluebird Bio Investor Information
About 40.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluebird Bio has Price/Earnings To Growth (PEG) ratio of 0.32. The entity recorded a loss per share of 20.59. The firm had not issued any dividends in recent years. Bluebird Bio had 1:20 split on the 13th of December 2024. Based on the analysis of Bluebird Bio's profitability, liquidity, and operating efficiency, Bluebird Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Bluebird Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bluebird Bio has an asset utilization ratio of 18.21 percent. This indicates that the Company is making $0.18 for each dollar of assets. An increasing asset utilization means that Bluebird Bio is more efficient with each dollar of assets it utilizes for everyday operations.Bluebird Bio Ownership Allocation
The market capitalization of Bluebird Bio is $48.67 Million. 30% of Bluebird Bio outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Bluebird Bio Profitability Analysis
The company reported the previous year's revenue of 83.81 M. Net Loss for the year was (240.72 M) with profit before overhead, payroll, taxes, and interest of 28.19 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bluebird Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bluebird Bio and how it compares across the competition.
About Bluebird Bio Valuation
The delisted stock valuation mechanism determines Bluebird Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bluebird Bio. We calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bluebird Bio's related companies.bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people.
Bluebird Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bluebird Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9.7 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Bluebird Stock
If you are still planning to invest in Bluebird Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bluebird Bio's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |